Home / Markets / Capital Market News / Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Last Updated : Aug 05 2024 | 9:05 AM IST

Sales rise 6.96% to Rs 814.65 crore

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended June 2024 as against Rs 132.25 crore during the previous quarter ended June 2023. Sales rose 6.96% to Rs 814.65 crore in the quarter ended June 2024 as against Rs 761.66 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales814.65761.66 7 OPM %28.3018.89 -PBDT265.81180.04 48 PBT249.40163.68 52 NP182.33132.25 38

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

Lagnam Spintex standalone net profit rises 16.18% in the June 2024 quarter

Patels Airtemp (India) standalone net profit rises 58.13% in the June 2024 quarter

Pritika Engineering Components consolidated net profit rises 1.08% in the June 2024 quarter

Par Drugs & Chemicals standalone net profit rises 2.43% in the June 2024 quarter

India's forex reserves decline by $3.471 billion to $667.386 billion

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 05 2024 | 7:36 AM IST